{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "69315-239",
      "generic_name": "CARBINOXAMINE MALEATE",
      "labeler_name": "Leading Pharma, LLC",
      "brand_name": "CARBINOXAMINE MALEATE",
      "active_ingredients": [
        {
          "name": "CARBINOXAMINE MALEATE",
          "strength": "6 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "69315-239-01",
          "description": "100 TABLET in 1 BOTTLE (69315-239-01)",
          "marketing_start_date": "20250801",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Leading Pharma, LLC"
        ],
        "rxcui": [
          "1795581"
        ],
        "spl_set_id": [
          "02e13b55-2153-468e-a5bd-57dee062f47f"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "02O55696WH"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "a6ac5a29-dc4e-425f-bcaf-d362b08e887c",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20250801",
      "product_id": "69315-239_a6ac5a29-dc4e-425f-bcaf-d362b08e887c",
      "application_number": "ANDA215476",
      "brand_name_base": "CARBINOXAMINE MALEATE",
      "pharm_class": [
        "Histamine H1 Receptor Antagonists [MoA]",
        "Histamine-1 Receptor Antagonist [EPC]"
      ]
    }
  ]
}